STK-001 - Single Ascending Doses for epilepsies, myoclonic

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 22 Jun 2020: Trial registered, NCT04442295
  2. 29 Jun 2020: Trial started, NCT04442295

The trials

NCT04442295: An Open-Label Study to Investigate the Safety of Single and Multiple Ascending Doses in Children and Adolescents With Dravet Syndrome

State
Completed
Phase
Phase 1 and Phase 2
People
62 taking part
Started
29 Jun 2020
Primary completion
14 Nov 2023
Arms
Single Ascending Doses
Results
None posted
  1. 22 Jun 2020: Trial registered
  2. 29 Jun 2020: Trial started
  3. 14 Nov 2023: Trial completed

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.